Satoh & Co., Ltd. (TYO:9996)

Regulus Therapeutics Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	1,724	4,183	1,626	1,780	2,448
Short-Term Investments	7,000	8,900	9,600	10,600	9,300
Cash & Short-Term Investments	8,724	13,083	11,226	12,380	11,748
Cash Growth	-33.32%	16.54%	-9.32%	5.38%	5.19%
Accounts Receivable	4,811	5,121	4,755	4,073	4,643
Other Receivables	473	456	418	329	301
Receivables	5,284	5,577	5,173	4,402	4,944
Inventory	2,980	2,605	2,657	2,206	2,033
Prepaid Expenses	34	33	31	24	27
Other Current Assets	105	98	79	56	35
Total Current Assets	17,127	21,396	19,166	19,068	18,787
Property, Plant & Equipment	6,735	6,243	6,200	5,796	5,577
Long-Term Investments	11,495	9,141	7,682	6,103	7,593
Other Intangible Assets	148	177	171	216	173
Long-Term Deferred Tax Assets	91	115	126	127	96
Other Long-Term Assets	1	2	1	3	1
Total Assets	35,597	37,074	33,346	31,313	32,227
Accounts Payable	6,322	8,236	6,195	5,157	5,945
Accrued Expenses	557	567	526	461	432
Short-Term Debt	683	683	683	683	683
Current Income Taxes Payable	990	1,466	914	633	658
Other Current Liabilities	376	392	325	397	82
Total Current Liabilities	8,928	11,344	8,643	7,331	7,800
Long-Term Leases	-	1	1	2	1
Other Long-Term Liabilities	132	112	94	77	83
Total Liabilities	9,330	11,761	9,022	7,686	8,146
Common Stock	1,405	1,405	1,405	1,405	1,405
Additional Paid-In Capital	1,441	1,441	1,441	1,441	1,441
Retained Earnings	24,318	23,353	22,426	21,708	21,348
Treasury Stock	-999	-999	-999	-999	-188
Comprehensive Income & Other	102	113	51	72	75
Shareholders' Equity	26,267	25,313	24,324	23,627	24,081
Total Liabilities & Equity	35,597	37,074	33,346	31,313	32,227
Total Debt	683	684	684	685	684
Net Cash (Debt)	8,041	12,399	10,542	11,695	11,064
Net Cash Growth	-35.15%	17.61%	-9.86%	5.70%	5.54%
Net Cash Per Share	964.15	1486.69	1264.03	1328.68	1237.58
Filing Date Shares Outstanding	8.34	8.34	8.34	8.34	8.94
Total Common Shares Outstanding	8.34	8.34	8.34	8.34	8.94
Working Capital	8,199	10,052	10,523	11,737	10,987
Book Value Per Share	3149.44	3035.02	2916.41	2832.81	2693.46
Tangible Book Value	26,119	25,136	24,153	23,411	23,908
Tangible Book Value Per Share	3131.69	3013.79	2895.90	2806.91	2674.11

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.